M. Dimitriu

First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas

L. Lévy, X. Buy, P. Terrier, 2016, Clinical Cancer Research.

First Human Study Testing a New Radio Enhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas

L. Lévy, X. Buy, P. Terrier, 2016 .

Phase I study of NBTXR3 nanoparticles, in patients with advanced soft tissue sarcoma (STS).

L. Lévy, X. Buy, P. Terrier, 2014 .

Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx.

S. Salas, V. Moreno, X. Mirabel, 2021, European journal of cancer.

Final safety and HRQoL results of the phase II/III Act.In.Sarc study with preoperative NBTXR3 plus radiotherapy versus radiotherapy in locally advanced soft-tissue sarcoma.

P. Ágoston, E. Wardelmann, V. Servois, 2022, International journal of radiation oncology, biology, physics.

First-inHuman Study Testing a New Radioenhancer Using Nanoparticles ( NBTXR 3 ) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas

L. Lévy, X. Buy, P. Terrier, 2016 .